No connection

Search Results

NYXH vs OWLT

NYXH
Nyxoah SA
BEARISH
Price
$3.38
Market Cap
$147.4M
Sector
Healthcare
AI Confidence
85%
OWLT
Owlet, Inc.
BEARISH
Price
$4.94
Market Cap
$139.1M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
NYXH
--
OWLT
--
Forward P/E
NYXH
-2.22
OWLT
92.63
P/B Ratio
NYXH
2.53
OWLT
6.99
P/S Ratio
NYXH
14.71
OWLT
1.32
EV/EBITDA
NYXH
-1.72
OWLT
-15.98

Profitability

Gross Margin
NYXH
63.13%
OWLT
50.64%
Operating Margin
NYXH
-329.29%
OWLT
-18.4%
Profit Margin
NYXH
0.0%
OWLT
-37.54%
ROE
NYXH
-110.95%
OWLT
-802.47%
ROA
NYXH
-37.67%
OWLT
-7.64%

Growth

Revenue Growth
NYXH
346.9%
OWLT
29.6%
Earnings Growth
NYXH
--
OWLT
--

Financial Health

Debt/Equity
NYXH
0.86
OWLT
0.42
Current Ratio
NYXH
1.25
OWLT
1.85
Quick Ratio
NYXH
1.14
OWLT
1.32

Dividends

Dividend Yield
NYXH
--
OWLT
--
Payout Ratio
NYXH
0.0%
OWLT
0.0%

AI Verdict

NYXH BEARISH

NYXH exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. While the company shows explosive revenue growth (346.90% YoY) and maintains a strong gross margin of 63.13%, these are overshadowed by an unsustainable operating margin of -329.29% and a consistent track record of earnings misses. The stock is technically in a freefall with a 0/100 trend score and a 1-year price decline of 43.6%. Despite bullish analyst price targets, the deterministic data suggests a high-risk speculative profile with significant capital erosion.

Strengths
Hyper-growth in revenue (346.90% YoY)
Strong Gross Margin (63.13%) indicating product value
Manageable Debt/Equity ratio (0.86)
Risks
Extreme cash burn reflected in -329.29% operating margin
Critical fundamental health (Piotroski F-Score 1/9)
Severe negative price momentum (0/100 Technical Trend)
OWLT BEARISH

OWLT exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of financial health metrics. While the company maintains strong revenue growth (29.6% YoY) and a healthy gross margin (50.64%), these are completely offset by catastrophic profitability, evidenced by an ROE of -802.47% and a massive collapse in EPS. The stock is in a clear technical downtrend, losing nearly 48% of its value in the last six months, and is further pressured by bearish insider activity from the CEO and CFO. Despite a high analyst target price of $14.25, the deterministic data suggests a high-risk profile with no clear path to near-term profitability.

Strengths
Strong YoY revenue growth of 29.60%
Healthy gross margin of 50.64%
Reasonable current ratio (1.85) indicating short-term liquidity
Risks
Critical financial health (Piotroski F-Score 1/9)
Extreme negative ROE (-802.47%) indicating massive capital erosion
Severe earnings collapse with Q/Q EPS growth of -1400%

Compare Another Pair

NYXH vs OWLT: Head-to-Head Comparison

This page compares Nyxoah SA (NYXH) and Owlet, Inc. (OWLT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile